Company Description
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide.
The company's products include BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of antioxidant carotenoids.
It also provides contract extraction and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets.
Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
| Country | HI |
| Founded | 1983 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 77 |
| CEO | Matthew Keith Custer |
Contact Details
Address: 73-4460 Queen Kaahumanu Hwy, Suite 102 Kailua Kona, Hawaii 96740 United States | |
| Phone | 8083261353 |
| Website | cyanotech.com |
Stock Details
| Ticker Symbol | CYAN |
| Exchange | OTCMKTS |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0000768408 |
| CUSIP Number | 232437301 |
| ISIN Number | BMG7403L1046 |
| Employer ID | 91-1206026 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Dr. Gerald R. Cysewski Ph.D. | Co-Founder, Chief Executive Officer Emeritus and Chief Scientific Officer |
| Matthew Keith Custer | President, Chief Executive Officer and Director |
| Felicia I. Ladin | Chief Financial Officer and Vice President of Finance & Administration and Treasurer |
| Glenn D. Jensen | Vice President of Operations |
| Charles J. Hartmann | Vice President of Sales and Marketing |
| Amy Beth Nordin | Vice President of Human Resources and Corporate Secretary |
| Collette Kakuk | Chief Strategic and Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 28, 2024 | PRE 14A | Other preliminary proxy statements |
| Jun 26, 2024 | 10-K | Annual Report |
| Apr 9, 2024 | 25-NSE | Filing |
| Feb 14, 2024 | 8-K | Current Report |
| Feb 8, 2024 | 10-Q | Quarterly Report |
| Dec 20, 2023 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Dec 19, 2023 | 8-K | Current Report |
| Nov 8, 2023 | 10-Q | Quarterly Report |
| Aug 30, 2023 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Aug 29, 2023 | 8-K | Current Report |